MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Operating Expenses 2011-2026 | BRKR
Annual Operating Expenses Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 B | 1.08 B | 873 M | 796 M | 678 M | 696 M | 631 M | 583 M | 546 M | 557 M | 646 M | 634 M | 649 M | 584 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 B | 546 M | 739 M |
Quarterly Operating Expenses Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 431 M | 359 M | - | 351 M | 336 M | 288 M | - | 258 M | 254 M | 237 M | - | 204 M | 224 M | 210 M | - | 196 M | 195 M | 190 M | - | 167 M | 148 M | 176 M | - | 166 M | 177 M | 173 M | - | 154 M | 156 M | 161 M | - | 148 M | 149 M | 139 M | - | 139 M | 150 M | 133 M | - | 139 M | 138 M | 145 M | - | 162 M | 165 M | 159 M | - | 162 M | 158 M | 162 M | - | 150 M | 166 M | 156 M | - | 152 M | 145 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 431 M | 133 M | 190 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medtronic PLC
MDT
|
15.3 B | $ 87.12 | 0.62 % | $ 112 B |  USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.13 | 6.22 % | $ 1.29 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 11.97 | 2.13 % | $ 474 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.3 | -0.4 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
38.2 M | $ 102.82 | 1.83 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.66 | 1.8 % | $ 65.2 M | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 225.87 | 0.16 % | $ 15.9 B | USA |
 |
AxoGen
AXGN
|
121 M | $ 33.16 | 1.69 % | $ 1.53 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.85 | 0.72 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
AVITA Medical
RCEL
|
101 M | $ 4.04 | 5.21 % | $ 113 M |  Australia |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.7 | 0.2 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.65 | -7.27 % | $ 35.4 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.25 | 3.94 % | $ 3.51 M | USA |
 |
InspireMD
NSPR
|
52.3 M | $ 1.79 | 1.13 % | $ 115 M | Israel |
 |
Profound Medical Corp.
PROF
|
33 M | $ 5.23 | 1.55 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.62 | 1.95 % | $ 7.27 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.61 | 1.13 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.72 | 3.24 % | $ 30.1 M | USA |
 |
Smith & Nephew plc
SNN
|
2.67 B | $ 32.46 | 0.92 % | $ 23.8 B |  Britain |
 |
Penumbra
PEN
|
753 M | $ 335.79 | 0.46 % | $ 13.1 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.4 | - | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.69 | -5.63 % | $ 138 M |  France |
 |
Sensus Healthcare
SRTS
|
22.2 M | $ 3.96 | - | $ 64.7 M | USA |
 |
Quanterix Corporation
QTRX
|
191 M | $ 3.95 | 3.4 % | $ 168 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.04 | 0.82 % | $ 376 M | USA |
 |
Outset Medical
OM
|
113 M | $ 3.56 | 0.85 % | $ 54.2 K | USA |